High-dose-rate brachytherapy boost for prostate cancer: rationale and technique

GC Morton - Journal of contemporary brachytherapy, 2014 - termedia.pl
Purpose Patients diagnosed with localized prostate cancer face a myriad of established
treatment options including active surveillance, radical prostatectomy, external beam …

Brachytherapy for prostate cancer: Present and future

JM Hannoun-Lévi - Cancer/Radiothérapie, 2017 - Elsevier
Based on recent, important publications on the impact of brachytherapy in the management
of prostate cancer, we analysed already validated indications and the “under investigations” …

Prostate cancer high dose-rate brachytherapy: review of evidence and current perspectives

SW Dutta, CE Alonso, B Libby… - Expert review of medical …, 2018 - Taylor & Francis
Introduction: Patients with intermediate to high risk disease (prostate specific antigen
(PSA)≥ 10, Gleason score≥ 7, or clinical stage≥ T2b) suffer from poorer long-term …

Brachytherapy for prostate cancer: a systematic review

G Koukourakis, N Kelekis, V Armonis… - Advances in …, 2009 - Wiley Online Library
Low‐dose rate brachytherapy has become a mainstream treatment option for men
diagnosed with prostate cancer because of excellent long‐term treatment outcomes in low …

The emerging role of high-dose-rate brachytherapy for prostate cancer

GC Morton - Clinical Oncology, 2005 - Elsevier
By placing radioactive sources directly into the cancer, brachytherapy allows delivery of a
highly conformal radiation dose to the prostate. Permanent seed brachytherapy is most …

Brachytherapy: current status and future strategies—can high dose rate replace low dose rate and external beam radiotherapy?

GC Morton, PJ Hoskin - Clinical Oncology, 2013 - Elsevier
Brachytherapy delivers the most conformal high dose radiotherapy possible to the prostate,
using either a low dose rate (LDR) or high dose rate (HDR) technique. It may be used either …

American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy

Y Yamada, L Rogers, DJ Demanes, G Morton… - Brachytherapy, 2012 - Elsevier
PURPOSE: A well-established body of literature supports the use of high-dose-rate (HDR)
brachytherapy as definitive treatment for localized prostate cancer. Most of the articles …

Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer

ICJ Hsu, AR Cabrera, V Weinberg, J Speight… - Brachytherapy, 2005 - Elsevier
PURPOSE: This is a retrospective review of our experience using high-dose-rate (HDR)
brachytherapy boost for prostate cancer. METHODS AND MATERIALS: During the study …

[HTML][HTML] Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer

R Kotecha, Y Yamada, X Pei, MA Kollmeier, B Cox… - Brachytherapy, 2013 - Elsevier
PURPOSE: To report prostate-specific antigen (PSA) relapse-free survival and treatment-
related toxicity outcomes after combining high-dose-rate (HDR) brachytherapy with external …

[HTML][HTML] Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial …

JM Hudson, A Loblaw, M McGuffin, HT Chung… - Radiotherapy and …, 2024 - Elsevier
Abstract Background and Purpose High dose-rate (HDR) brachytherapy as a monotherapy
is an accepted treatment for localized prostate cancer, but the optimal dose and fractionation …